Heranba Industries, one of the leading manufacturers of synthetic pyrethroids in India, has launched its initial public offering (IPO) on Tuesday, at a price band between Rs626-627 per equity share.
The IPO will be available for subscription till February 25, 2021.
The IPO comprises fresh issue aggregating to Rs60cr and an offer for sale (OFS) for about 90,15,000 Equity Shares (including an Anchor portion of 29,90,520 equity shares).
Through the issue, the company plans to raise about Rs625cr.
Bid lot size involves 23 Equity Shares and in multiples thereof.
On Monday, the company raised about Rs187.51cr from 18 anchor investors. Heranba allotted 29.91 lakh shares to these investors.
Companies like Emkay Global Financial Services and Batlivala & Karani Securities India - are acting as Book Running Lead Managers (BRLM) for the issue.
Related Tags: